1 ANNEX, Regulation (EU) 2018/1262

In forcesince 20 Sep 2018

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2019’;

(2)

in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2019’;

(3)

in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2019’;

(4)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2019’;

(5)

in the sixth column, expiration of approval, of row 67, Dimethenamid-p, the date is replaced by ‘31 October 2019’;

(6)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2019’;

(7)

in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2019’;

(8)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2019’;

(9)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2019’;

(10)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2019’;

(11)

in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2019’;

(12)

in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2019’;

(13)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2019’;

(14)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2019’;

(15)

in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2019’;

(16)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2019’;

(17)

in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2019’;

(18)

in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2019’;

(19)

in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2019’;

(20)

in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2019’.